The Skinny on GLP-1s: Part 1

 A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.  



Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.   



These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. 



Check out our other GLP1 content



David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video (https://www.primetherapeutics.com/new...)



Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year (https://www.primetherapeutics.com/new...)

------------------------------------------------------------------



More about Prime (https://www.primetherapeutics.com/)



News and information (https://www.primetherapeutics.com/news/)